Niranjan Kulkarni Presents “Supply Chain Challenges: Drug Substance is Easy” at ISPE Biopharmaceutical Manufacturing Conference

Niranjan Kulkarni Presents “Supply Chain Challenges: Drug Substance is Easy” at ISPE Biopharmaceutical Manufacturing Conference
Posted: Nov 27 2017
Niranjan Kulkarni, PhD, Director, Operations Improvement, will be presenting “Supply Chain Challenges: Drug Substance is Easy” at this year’s ISPE Biopharmaceutical Manufacturing Conference held in San Francisco, California, December 4th- 6th

Dr. Kulkarni's presentation will be on December 4th from 1:00--2:30 pm and will include Mr. William J. Collingwood, Head of Supply Chain, Biologics – AstraZeneca and be led by Mr. Darren M. Dasburg, Vice President and Site Head, Boulder Manufacturing Center – AstraZeneca.

The presentation will address why designing for cold chain execution is a key enabler of delivering a lean execution and high right first time logistics execution for biologic products. And how investing early in the development phase for products facilitates a robust scalable cold chain solution that mitigates risk, maintains high customer service and optimizes costs.

There was a time not so long ago when we all fretted about drug substance and the ocean of stainless costing hundreds of millions of dollars to get in place. Recently the marketplace and our internal businesses are pivoting to the immense questions of supply chain execution post drug substance. With dozens of markets for new products and the technicalities of getting bio products into the markets, we can see just two molecules equating to hundreds of launch activities. Additionally, the pressures of any normal business drive us to hedge our inputs and create newer more flexible supply solutions. These experts draw the parallels and give keen insight into how to process the emerging realities.

Click here to register: https://www.ispe.org/conferences/2017-biopharmaceutical-manufacturing-conference/education

Search News